G
GLAB
vs
S
S&P TSX Composite Index (Canada)
Over the past 12 months, GLAB has underperformed S&P TSX Composite Index (Canada), delivering a return of -96% compared to the S&P TSX Composite Index (Canada)'s +35% growth.
Stocks Performance
GLAB vs S&P TSX Composite Index (Canada)
Performance Gap
GLAB vs S&P TSX Composite Index (Canada)
Performance By Year
GLAB vs S&P TSX Composite Index (Canada)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Gemina Laboratories Ltd
Glance View
Gemina Laboratories Ltd. (Gemina) is a Canada-based biotechnology company. Gemina operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. It is engaged in biosensor and diagnostic services with a transformative, patented, proprietary chemistry that powers next-generation testing platforms for a wide range of pathogens that affect human health and wellness. Gemina's technology drives testing platforms that are fast, affordable and accurate, and easily self-administered. Its development pipeline includes platforms for the rapid testing of COVID-19, influenza and other viruses. Gemina is focused on infectious respiratory diseases and the recovery from them. It has developed a first-generation technology (the Generation 1 Technology), which it has included within an initial demonstration product namely: a point-of-care lateral flow assay to test whether a person is infected with COVID-19 (the Legio-XTM COVID Rapid Antigen Test).
